| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Surgery (J.L., K.L.O., C.M.T., B.M.E.), Sealy Center for Cancer Cell Biology (J.L., K.L.O., X.C., B.M.E.), Department of Pharmacology and Toxicology (X.C., F.C.M.), and Office of Biostatistics (T.U.), The University of Texas Medical Branch, Galveston, Texas 77555
Address all correspondence and requests for reprints to: B. Mark Evers, M.D., Department of Surgery, The University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555-0536. E-mail: mevers{at}utmb.edu.
Neurotensin (NT), a gut peptide, plays important roles in gastrointestinal secretion, inflammation, and growth of normal and neoplastic tissues. cAMP regulates the secretion of hormones via its effector proteins protein kinase A (PKA) or Epac (exchange protein directly activated by cAMP). The small GTPase Rap1 can be activated by both PKA and Epac; however, the role of Rap1 in hormone secretion is unknown. Here, using the BON human endocrine cell line, we found that forskolin (FSK)-stimulated NT secretion was reduced by inhibition of Rap1 expression and activity. FSK-stimulated NT secretion was enhanced by overexpression of either wild-type or constitutively active Rap1. Epac activators and wild-type Epac enhanced NT release and Rap1 activity. In contrast, overexpression of a cAMP binding mutant, EpacR279E, decreased NT release and Rap1 activity. PKA activation increased NT release and Rap1 activity. FSK-stimulated NT release was reduced by PKA inhibition and the dominant negative Rap1N17. NT secretion, stimulated by Epac activation, was reduced by PKA inhibition; NT release, stimulated by PKA activation, was enhanced by wild-type Epac but reduced by the mutant EpacR279E. Finally, prostaglandin E2 (PGE2), a physiological agent that increases cAMP, stimulated NT secretion via cAMP/PKA/Rap1. Importantly, we demonstrate that PKA and Epac mediate the cAMP-induced NT secretion synergistically by converging at the common downstream target protein Rap1. Moreover, PGE2, a potent mediator of inflammation and associated with colorectal carcinogenesis, stimulates NT release suggesting a possible link between PGE2 and NT on intestinal inflammatory disorders and colorectal cancers.
This article has been cited by other articles:
![]() |
M. E. Sabbatini, X. Chen, S. A. Ernst, and J. A. Williams Rap1 Activation Plays a Regulatory Role in Pancreatic Amylase Secretion J. Biol. Chem., August 29, 2008; 283(35): 23884 - 23894. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Das, M. T. Mazhab-Jafari, S. Chowdhury, S. SilDas, R. Selvaratnam, and G. Melacini Entropy-driven cAMP-dependent Allosteric Control of Inhibitory Interactions in Exchange Proteins Directly Activated by cAMP J. Biol. Chem., July 11, 2008; 283(28): 19691 - 19703. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Yokoyama, H. H. Patel, N. C. Lai, N. Aroonsakool, D. M. Roth, and P. A. Insel The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals PNAS, April 29, 2008; 105(17): 6386 - 6391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, L. A. Chen, C. M. Townsend Jr., and B. M. Evers PKD1, PKD2, and Their Substrate Kidins220 Regulate Neurotensin Secretion in the BON Human Endocrine Cell Line J. Biol. Chem., February 1, 2008; 283(5): 2614 - 2621. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Wayne, H.-Y. Fan, X. Cheng, and J. S. Richards Follicle-Stimulating Hormone Induces Multiple Signaling Cascades: Evidence that Activation of Rous Sarcoma Oncogene, RAS, and the Epidermal Growth Factor Receptor Are Critical for Granulosa Cell Differentiation Mol. Endocrinol., August 1, 2007; 21(8): 1940 - 1957. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |